Evaluation of the mevalonate pathway as a target for the treatment of ovarian cancer
Ovarian cancer is the 5th leading cause of cancer-related death. The disease responds initially to treatment which is most often surgical cytoreduction followed by chemotherapy. The primary response rates to chemotherapy are approximately 80%. Unfortunately, most patients relapse and eventually tumo...
| Main Author: | |
|---|---|
| Published: |
Keele University
2018
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.739438 |